The Italian Registry of Pulmonary Non-tuberculous Mycobacteria - IRENE: the Study Protocol

Background: A substantial increase in pulmonary and extra-pulmonary diseases due to non-tuberculous mycobacteria (NTM) has been documented worldwide, especially among subjects suffering from chronic respiratory diseases and immunocompromised patients. Many questions remain regarding the epidemiology of pulmonary disease due to NTM (NTM-PD) mainly because reporting of NTM-PD to health authorities is not mandated in several countries, including Italy. This manuscript describes the protocol of the first Italian registry of adult patients with respiratory infections caused by NTM (IRENE).

Methods: IRENE is an observational, multicenter, prospective, cohort study enrolling consecutive adult patients with either a NTM respiratory isolate or those with NTM-PD. A total of 41 centers, including mainly pulmonary and infectious disease departments, joined the registry so far. Adult patients with all of the following are included in the registry: 1) at least one positive culture for any NTM species from any respiratory sample; 2) at least one positive culture for NTM isolated in the year prior the enrolment and/or prescribed NTM treatment in the year prior the enrolment; 3) given consent to inclusion in the study. No exclusion criteria are applied to the study. Patients are managed according to standard operating procedures implemented in each IRENE clinical center. An online case report form has been developed to collect patients' demographics, comorbidities, microbiological, laboratory, functional, radiological, clinical, treatment and outcome data at baseline and on an annual basis. An IRENE biobank has also been developed within the network and linked to the clinical data of the registry.

Conclusions: IRENE has been developed to inform the clinical and scientific community on the current management of adult patients with NTM respiratory infections in Italy and acts as a national network to increase the disease's awareness.

Trial Registration: Clinicaltrial.gov: NCT03339063.

Citing Articles

Prescription habits and drugs accessibility for the treatment of non-tuberculous mycobacteria infections in Italy: a multicentric survey from the IRENE study group.

Stroffolini G, Lupia T, Gaviraghi A, Venuti F, Cinnirella G, Gori A Infection. 2024; 53(1):383-392.

PMID: 39302627 PMC: 11825620. DOI: 10.1007/s15010-024-02390-y.

European Respiratory Society International Congress, Madrid, 2019: nontuberculous mycobacterial pulmonary disease highlights.

Chalmers J, Balavoine C, Castellotti P, Hugel C, Payet A, Wat D ERJ Open Res. 2020; 6(4).

PMID: 33123559 PMC: 7569164. DOI: 10.1183/23120541.00317-2020.

Non-tuberculous mycobacterial lung disease in patients with bronchiectasis: perceived risk, severity and guideline adherence in a European physician survey.

Wagner D, van Ingen J, van der Laan R, Obradovic M BMJ Open Respir Res. 2020; 7(1).

PMID: 32332023 PMC: 7204844. DOI: 10.1136/bmjresp-2019-000498.

Protocol of a Nationwide Observational Study among Patients with Nontuberculous Mycobacterium Pulmonary Disease in South Korea (NTM-KOREA).

Kwak N, Choi H, Jeon D, Jhun B, Jo K, Kang Y Tuberc Respir Dis (Seoul). 2020; 83(2):141-146.

PMID: 32185919 PMC: 7105436. DOI: 10.4046/trd.2019.0077.

Get together to increase awareness in bronchiectasis: a report of the 2 World Bronchiectasis Conference.

Aliberti S, Chalmers J Multidiscip Respir Med. 2018; 13(Suppl 1):28.

PMID: 30151189 PMC: 6101068. DOI: 10.1186/s40248-018-0138-3.

References

Hoefsloot W, van Ingen J, Andrejak C, Angeby K, Bauriaud R, Bemer P . The geographic diversity of nontuberculous mycobacteria isolated from pulmonary samples: an NTM-NET collaborative study. Eur Respir J. 2013; 42(6):1604-13. DOI: 10.1183/09031936.00149212. View

Goutaki M, Maurer E, Halbeisen F, Amirav I, Barbato A, Behan L . The international primary ciliary dyskinesia cohort (iPCD Cohort): methods and first results. Eur Respir J. 2017; 49(1). PMC: 5298195. DOI: 10.1183/13993003.01181-2016. View

Kendall B, Winthrop K . Update on the epidemiology of pulmonary nontuberculous mycobacterial infections. Semin Respir Crit Care Med. 2013; 34(1):87-94. DOI: 10.1055/s-0033-1333567. View

Henry M, Inamdar L, ORiordain D, Schweiger M, Watson J . Nontuberculous mycobacteria in non-HIV patients: epidemiology, treatment and response. Eur Respir J. 2004; 23(5):741-6. DOI: 10.1183/09031936.04.00114004. View

McDonnell M, Aliberti S, Goeminne P, Dimakou K, Zucchetti S, Davidson J . Multidimensional severity assessment in bronchiectasis: an analysis of seven European cohorts. Thorax. 2016; 71(12):1110-1118. PMC: 5136700. DOI: 10.1136/thoraxjnl-2016-208481. View

Rindi L, Garzelli C . Increase in non-tuberculous mycobacteria isolated from humans in Tuscany, Italy, from 2004 to 2014. BMC Infect Dis. 2016; 16:44. PMC: 4736237. DOI: 10.1186/s12879-016-1380-y. View

Brode S, Daley C, Marras T . The epidemiologic relationship between tuberculosis and non-tuberculous mycobacterial disease: a systematic review. Int J Tuberc Lung Dis. 2014; 18(11):1370-7. DOI: 10.5588/ijtld.14.0120. View

van Ingen J, Bendien S, de Lange W, Hoefsloot W, Dekhuijzen P, Boeree M . Clinical relevance of non-tuberculous mycobacteria isolated in the Nijmegen-Arnhem region, The Netherlands. Thorax. 2009; 64(6):502-6. DOI: 10.1136/thx.2008.110957. View

Diel R, Jacob J, Lampenius N, Loebinger M, Nienhaus A, Rabe K . Burden of non-tuberculous mycobacterial pulmonary disease in Germany. Eur Respir J. 2017; 49(4). DOI: 10.1183/13993003.02109-2016. View

10.

Mencarini J, Cresci C, Simonetti M, Truppa C, Camiciottoli G, Frilli M . Non-tuberculous mycobacteria: epidemiological pattern in a reference laboratory and risk factors associated with pulmonary disease. Epidemiol Infect. 2016; 145(3):515-522. PMC: 9507663. DOI: 10.1017/S0950268816002521. View

11.

Biondi G, Sotgiu G, Dore S, Molicotti P, Ruggeri M, Aliberti S . Beyond pulmonary nontuberculous mycobacteria disease: do extra-pulmonary forms represent an emerging clinical and public health threat?. ERJ Open Res. 2017; 3(3). PMC: 5603771. DOI: 10.1183/23120541.00091-2017. View

12.

Moore J, Kruijshaar M, Ormerod L, Drobniewski F, Abubakar I . Increasing reports of non-tuberculous mycobacteria in England, Wales and Northern Ireland, 1995-2006. BMC Public Health. 2010; 10:612. PMC: 2964631. DOI: 10.1186/1471-2458-10-612. View

13.

Faverio P, Stainer A, Bonaiti G, Zucchetti S, Simonetta E, Lapadula G . Characterizing Non-Tuberculous Mycobacteria Infection in Bronchiectasis. Int J Mol Sci. 2016; 17(11). PMC: 5133910. DOI: 10.3390/ijms17111913. View

14.

Bryant J, Grogono D, Rodriguez-Rincon D, Everall I, Brown K, Moreno P . Emergence and spread of a human-transmissible multidrug-resistant nontuberculous mycobacterium. Science. 2016; 354(6313):751-757. PMC: 5142603. DOI: 10.1126/science.aaf8156. View

15.

Griffith D, Aksamit T, Brown-Elliott B, Catanzaro A, Daley C, Gordin F . An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med. 2007; 175(4):367-416. DOI: 10.1164/rccm.200604-571ST. View

16.

DAmbrosio L, Tadolini M, Centis R, Duarte R, Sotgiu G, Aliberti S . Supporting clinical management of the difficult-to-treat TB cases: the ERS-WHO TB Consilium. Int J Infect Dis. 2015; 32:156-60. DOI: 10.1016/j.ijid.2014.12.024. View

17.

Aliberti S, Peyrani P, Filardo G, Mirsaeidi M, Amir A, Blasi F . Association between time to clinical stability and outcomes after discharge in hospitalized patients with community-acquired pneumonia. Chest. 2011; 140(2):482-488. DOI: 10.1378/chest.10-2895. View

18.

van der Werf M, Kodmon C, Katalinic-Jankovic V, Kummik T, Soini H, Richter E . Inventory study of non-tuberculous mycobacteria in the European Union. BMC Infect Dis. 2014; 14:62. PMC: 3922012. DOI: 10.1186/1471-2334-14-62. View

19.

Mirsaeidi M, Machado R, Garcia J, Schraufnagel D . Nontuberculous mycobacterial disease mortality in the United States, 1999-2010: a population-based comparative study. PLoS One. 2014; 9(3):e91879. PMC: 3954860. DOI: 10.1371/journal.pone.0091879. View

20.

Chalmers J, Aliberti S, Polverino E, Vendrell M, Crichton M, Loebinger M . The EMBARC European Bronchiectasis Registry: protocol for an international observational study. ERJ Open Res. 2016; 2(1). PMC: 5005162. DOI: 10.1183/23120541.00081-2015. View